Skip to main content

Jeremy Berg, Jim Golden, Roger Perlmutter


Jeremy Berg, currently director of the Institute for Basic Biomedical Sciences and professor and director of the department of biophysics and biophysical chemistry at Johns Hopkins University School of Medicine in Baltimore, has been named as the new director of the National Institute of General Medical Sciences.

Berg, who is expected to begin his new position in early November, will replace Judith Greenberg, who became acting director of NIGMS in May 2002 following the departure of Marvin Cassman, who had led the institute since 1993.

Jim Golden, formerly business development manager of Curagen’s sequencing technology spin-off, 454, has joined Cambridge Healthtech Institute as senior vice president and research director.

The Institute for Systems Biology has appointed Roger Perlmutter as chairman of its board of directors. Perlmutter currently serves as executive vice president of R&D at Amgen. He has been a member of ISB’s board since its inception in January 2000.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.